柔性内视镜市场 - 全球产业规模、份额、趋势、机会及按类型、最终用途、地区和竞争格局分類的预测（2021-2031年）

全球柔性内视镜市场预计将从 2025 年的 84.1 亿美元成长到 2031 年的 129.9 亿美元，复合年增长率为 7.51%。

柔性内视镜是一种将光学元件和工作通道整合到柔性插入管中的医疗设备，使医生能够透过自然腔道观察体内器官并进行手术。市场成长的主要驱动力是全球人口快速老化以及需要频繁诊断的慢性病发病率不断上升。此外，微创手术的普及也进一步推动了市场需求，因为微创手术的恢復时间比传统手术更短。例如，美国癌症协会估计，到2025年，美国将新增154,270例大肠癌病例，这将持续推高对内视镜检查的需求。

儘管有这些正面趋势，但市场在预防感染传播所需的严格再处理标准方面仍面临重大挑战。彻底消毒这些复杂的重复使用设备存在困难，这会使医疗机构面临责任风险并降低营运效率。这个问题会导致高昂的维护成本，并需要严格遵守监管规定，这可能会阻碍资源匮乏地区广泛采用此类设备。此外，医疗机构可能被迫承担一次性替代品的高成本。

市场驱动因素

一次性软式内视镜的快速普及正在从根本上改变市场格局，有效解决了交叉感染和器械供应等关键挑战。医疗机构正日益转向使用经过消毒的一次性器械，以降低复杂可重复使用器械再处理的风险，尤其是在加护病房等高使用率环境中。此外，消除昂贵的维修和消毒流程、提高营运效率也是推动这项转变的重要因素。市场对这些解决方案的强劲需求也反映在近期的公司业绩中。例如，Ambu A/S 在其 2024 年 11 月发布的 2023/24 年度报告中指出，其内视镜解决方案业务实现了 19.7% 的有机销售增长，主要得益于其在肺科和泌尿系统领域一次性产品系列的扩张。

同时，慢性消化器官系统和呼吸系统疾病的日益普遍正推动全球诊断和治疗性内视镜手术数量的成长。随着人口老化和风险因素暴露的增加，胃癌和肺癌等疾病负担日益加重，需要频繁的筛检和微创治疗。世界卫生组织（世卫组织）于2024年2月发布的《全球癌症负担日益加重》报告显示，肺癌仍是全球最常见的癌症类型，新增病例达250万例。这凸显了对先进支气管镜技术的迫切需求。这种快速成长的临床需求正直接转化为主要医疗设备製造商的显着收入成长。例如，波士顿科学公司内视镜部门2024年的年净销售额达到26.87亿美元，反映了其对这些技术的持续依赖。

市场挑战

为防止感染传播而製定的严格再处理标准是全球软式内视镜市场扩张的一大障碍。软式内视镜内部结构复杂，包含复杂的通道和升降机构，极易累积有机碎屑和生物膜，使得有效消毒极为困难且耗费人力。这种复杂性要求医疗机构投入大量资源用于清洁通讯协定，显着降低了设备周转率，并限制了每日接诊患者的数量。由此导致的营运效率降低和维护成本增加，阻碍了小规模医疗中心扩展其内视镜诊疗能力，从而限制了整体市场规模。

业界权威机构的安全数据凸显了器械再处理挑战的严峻性。根据欧洲感染控制研究所 (ECRI) 预测，到 2024 年，不充分或繁琐的设备清洁程序将被列为全球第二大医疗技术风险，这凸显了医疗机构在对复杂、可重复使用的器械进行消毒方面持续面临的困难。这种高风险状况要求严格遵守监管规定，这会消耗医院预算，并挤占原本可用于购买更多内视镜设备的资金。因此，与感染控制相关的财务和法律责任负担直接限制了可重复使用软式内视镜的广泛应用。

市场趋势

人工智慧 (AI) 驱动的即时病变检测技术的集成，透过在内镜检查过程中充当自动化的第二观察者，从根本上改变了诊断标准。这些系统利用深度学习演算法即时分析影像数据，识别潜在的异常情况，例如结肠息肉，而这些异常情况可能因疲劳或註意力分散而被人眼忽略。这项技术变革直接解决了医师腺瘤检出率差异这一临床难题，有效地建立了新的检查品质标准。随着主要製造商将人工智慧处理器整合到其旗舰平台中，这些功能的市场应用正在迅速加速。例如，Olympus Corporation在其 2024 年 5 月发布的「2024 财年合併会计」中报告称，其人工智慧 EVIS X1 系列产品在第四季度的销售额约占其胃肠内视镜部门总销售额的 30%，这标誌着公司正向智慧视觉化系统进行决定性的商业性转型。

同时，机器人辅助软式内视镜平台的出现正在扩大市场覆盖范围，尤其是在肺科复杂解剖路径的导航方面。与传统的手动支气管镜不同，这些机器人系统采用可弯曲导管和形状感知技术，在进入难以触及的外周肺结节时能够保持稳定性和精确性。这种增强的操控性显着提高了早期癌症切片检查的诊断率，促使医院将介入治疗能力扩展到标准范围之外。近期部署数据也印证了对这些先进平台的需求。根据直觉外科公司（Intuitive Surgical）于2024年10月发布的“2024年第三季度财务业绩”，Ion内视镜系统的全球部署量达到736台，同比增长50%，反映出该领域正稳步转向机器人导航解决方案。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球柔性内视镜市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（腹腔镜、关节镜、输尿管镜、膀胱镜、妇科内视镜、神经内视神经科学用内视镜、子宫镜、喉镜、鼻窦镜、耳镜、乙状结肠镜、咽镜、十二指肠镜、鼻咽镜、鼻镜、大肠镜）
  • 按用途（医院、门诊机构）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美柔性内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲柔性内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区柔性内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲柔性内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲柔性内视镜市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球柔性内视镜市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Olympus Corporation
• Richard Wolf GmbH
• Smith n Nephew Inc.
• FUJIFILM Holdings Corp.
• Ambu A/S
• Stryker Corporation
• Boston Scientific Corp
• Karl Storz SE & Co. KG
• Medtronic Plc
• Ethicon, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Flexible Endoscopes Market is projected to grow from USD 8.41 Billion in 2025 to USD 12.99 Billion by 2031, registering a CAGR of 7.51%. Flexible endoscopes are defined as medical instruments featuring a pliable insertion tube with integrated optics and working channels, enabling physicians to visualize internal organs and conduct procedures through natural body openings. Market growth is primarily driven by the rapidly aging global population and the rising incidence of chronic conditions necessitating frequent diagnostics. Furthermore, the shift toward minimally invasive surgeries supports demand, as these techniques offer shorter recovery times than traditional methods. For instance, the American Cancer Society estimates that 154,270 new cases of colorectal cancer will be diagnosed in the United States in 2025, ensuring sustained demand for endoscopic screening.

Despite this positive trajectory, the market faces a significant challenge regarding the rigorous reprocessing standards needed to prevent infection transmission. The difficulty inherent in thoroughly sterilizing these complex reusable devices creates liability risks and operational inefficiencies for healthcare providers. This issue leads to high maintenance costs and requires strict regulatory compliance, factors that may hinder broader adoption in resource-constrained settings or compel facilities to incur the high costs associated with disposable alternatives.

Market Driver

The rapid uptake of single-use and disposable flexible endoscopes is fundamentally reshaping the market by resolving critical issues regarding cross-contamination and device availability. Healthcare facilities are increasingly switching to sterile, single-use devices to mitigate risks associated with reprocessing complex reusable instruments, especially in high-volume environments like intensive care units. This transition is also motivated by the need to eliminate expensive repair and sterilization workflows, thereby enhancing operational efficiency. The strong market demand for these solutions is reflected in recent corporate performance; for example, Ambu A/S reported in November 2024 within its 'Annual Report 2023/24' that its Endoscopy Solutions business achieved 19.7% organic revenue growth, largely fueled by the expansion of its disposable product portfolio in pulmonology and urology.

Concurrently, the rising prevalence of chronic gastrointestinal and respiratory disorders is driving a higher volume of diagnostic and therapeutic endoscopic procedures globally. As populations age and exposure to risk factors grows, the burden of conditions such as gastric and lung cancers necessitates frequent screening and minimally invasive interventions. According to the World Health Organization's February 2024 'Global cancer burden growing' release, lung cancer was the most common cancer worldwide with 2.5 million new cases, highlighting the critical need for advanced bronchoscopic capabilities. This surging clinical demand translates directly into substantial financial expansion for leading device manufacturers; for instance, Boston Scientific recorded annual net sales of $2.687 billion for its Endoscopy business segment in 2024, reflecting sustained reliance on these technologies.

Market Challenge

The rigorous reprocessing standards required to prevent infection transmission act as a critical barrier impeding the expansion of the Global Flexible Endoscopes Market. Flexible endoscopes possess intricate internal channels and elevator mechanisms that are highly susceptible to retaining organic debris and biofilm, making effective sterilization exceptionally difficult and labor-intensive. This complexity forces healthcare facilities to dedicate significant resources to cleaning protocols, which considerably slows device turnover and limits daily patient throughput. The resulting operational inefficiencies and elevated maintenance costs discourage smaller healthcare centers from expanding their endoscopic capabilities, thereby stifling overall market volume.

The magnitude of this reprocessing challenge is highlighted by safety data from industry authorities. According to ECRI, in 2024, inadequate or onerous device cleaning instructions were ranked as the second highest health technology hazard globally, underscoring the persistent difficulty providers face in sterilizing complex reusable instruments. This heightened risk profile necessitates strict regulatory compliance that consumes hospital budgets, diverting funds that might otherwise be used to purchase additional endoscopic units. Consequently, the financial and liability burdens associated with infection control directly restrict the broader adoption of reusable flexible endoscopes.

Market Trends

The integration of Artificial Intelligence (AI) for real-time lesion detection is fundamentally altering diagnostic standards by serving as an automated second observer during endoscopic procedures. These systems utilize deep learning algorithms to analyze video feeds instantaneously, flagging potential abnormalities such as colorectal polyps that might be missed by the human eye due to fatigue or distraction. This technological shift directly addresses the clinical challenge of variable adenoma detection rates among physicians, effectively creating a new baseline for procedural quality. Market adoption of these capabilities is accelerating rapidly as major manufacturers embed AI-driven processors into their flagship platforms; for instance, Olympus Corporation reported in May 2024, in its 'Consolidated Financial Results for Fiscal 2024', that the sales ratio of the AI-capable EVIS X1 series rose to approximately 30% of the company's total Gastrointestinal Endoscopy sales in the fourth quarter, signaling a decisive commercial shift toward intelligent visualization systems.

Simultaneously, the emergence of robotic-assisted flexible endoscopy platforms is expanding the market's operational boundaries, particularly for navigating complex anatomical pathways in pulmonology. Unlike traditional manual bronchoscopes, these robotic systems employ articulating catheters and shape-sensing technology to maintain stability and precision when accessing peripheral lung nodules, which are often difficult to reach. This enhanced maneuverability significantly improves diagnostic yield for early-stage cancer biopsies, driving hospitals to upgrade their interventional capabilities beyond standard limits. The demand for these advanced platforms is evident in recent installation data; according to Intuitive Surgical's October 2024 'Q3 2024 Earnings Release', the global installed base of the Ion Endoluminal System increased 50% year-over-year to 736 units, reflecting the sector's robust transition toward robotic navigation solutions.

Key Market Players

• Olympus Corporation
• Richard Wolf GmbH
• Smith n Nephew Inc.
• FUJIFILM Holdings Corp.
• Ambu A/S
• Stryker Corporation
• Boston Scientific Corp
• Karl Storz SE & Co. KG
• Medtronic Plc
• Ethicon, Inc.

Report Scope

In this report, the Global Flexible Endoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Flexible Endoscopes Market, By Type

• Laparoscopes
• Arthroscopes
• Ureteroscopes
• Cystoscopes
• Gynecology Endoscopes
• Neuroendoscopes
• Bronchoscopes
• Hysteroscopes
• Laryngoscopes
• Sinuscopes
• Otoscopes
• Sigmoidoscopes
• Pharyngoscopes
• Duodenoscope
• Nasopharyngoscopes
• Rhinoscopes
• Colonoscopes

Flexible Endoscopes Market, By End Use

• Hospital
• Outpatients Facilities

Flexible Endoscopes Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Flexible Endoscopes Market.

Available Customizations:

Global Flexible Endoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flexible Endoscopes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes, Bronchoscopes, Hysteroscopes, Laryngoscopes, Sinuscopes, Otoscopes, Sigmoidoscopes, Pharyngoscopes, Duodenoscope, Nasopharyngoscopes, Rhinoscopes, Colonoscopes)
  • 5.2.2. By End Use (Hospital, Outpatients Facilities)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Flexible Endoscopes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Flexible Endoscopes Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End Use
  • 6.3.2. Canada Flexible Endoscopes Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End Use
  • 6.3.3. Mexico Flexible Endoscopes Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End Use

7. Europe Flexible Endoscopes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Flexible Endoscopes Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End Use
  • 7.3.2. France Flexible Endoscopes Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Flexible Endoscopes Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Flexible Endoscopes Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Flexible Endoscopes Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End Use

8. Asia Pacific Flexible Endoscopes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Flexible Endoscopes Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Flexible Endoscopes Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End Use
  • 8.3.3. Japan Flexible Endoscopes Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End Use
  • 8.3.4. South Korea Flexible Endoscopes Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Flexible Endoscopes Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End Use

9. Middle East & Africa Flexible Endoscopes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Flexible Endoscopes Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End Use
  • 9.3.2. UAE Flexible Endoscopes Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End Use
  • 9.3.3. South Africa Flexible Endoscopes Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End Use

10. South America Flexible Endoscopes Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Flexible Endoscopes Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End Use
  • 10.3.2. Colombia Flexible Endoscopes Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End Use
  • 10.3.3. Argentina Flexible Endoscopes Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Flexible Endoscopes Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Olympus Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Richard Wolf GmbH
• 15.3. Smith n Nephew Inc.
• 15.4. FUJIFILM Holdings Corp.
• 15.5. Ambu A/S
• 15.6. Stryker Corporation
• 15.7. Boston Scientific Corp
• 15.8. Karl Storz SE & Co. KG
• 15.9. Medtronic Plc
• 15.10. Ethicon, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer